Bipolar drugs sensitize various types of drug-resistant cancer cells, while few of them possess strong P-gp inhibitory activity and increase sensitization in anticancer drugs for the combined therapy of P-gp-overexpressing resistant cancer cells [21,22,23,24,25]. This evidence concerns the gene PGP and cancer.